SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-069928
Filing Date
2018-11-26
Accepted
2018-11-26 17:25:58
Documents
3
Period of Report
2018-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40656_18k.htm 8-K 29480
2 EX-1.1 a18-40656_1ex1d1.htm EX-1.1 279889
3 EX-5.1 a18-40656_1ex5d1.htm EX-5.1 9509
  Complete submission text file 0001104659-18-069928.txt   320122
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 181201498
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1